The latest advances of experimental research on targeted gene therapy for prostate cancer View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

2013-11

AUTHORS

Dongliang Pan, Lianchao Jin, Xianghua Zhang

ABSTRACT

The absence of effective therapies for castration-resistant prostate cancer (CRPC) establishes the need to develop novel therapeutic modality, such as targeted gene therapy, which is ideal for the treatment of CRPC. But its application has been limited due to lack of favorable gene vector and the reduction of “bystander effect”. Consequently, scientists all over the world focus their main experimental research on the following four aspects: targeted gene, vector, transfer means and comprehensive therapy. In this paper, we reviewed the latest advances of experimental research on targeted gene therapy for prostate cancer. More... »

PAGES

546-550

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/s10330-013-1241-8

DOI

http://dx.doi.org/10.1007/s10330-013-1241-8

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1052773128


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/10", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Technology", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1004", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical Biotechnology", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1112", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Oncology and Carcinogenesis", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Department of Urology Peking University Shougang Hospital, Wujieping Urology Medical Center, 100144, Beijing, China", 
          "id": "http://www.grid.ac/institutes/grid.452694.8", 
          "name": [
            "Department of Urology Peking University Shougang Hospital, Wujieping Urology Medical Center, 100144, Beijing, China"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Pan", 
        "givenName": "Dongliang", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Urology Peking University Shougang Hospital, Wujieping Urology Medical Center, 100144, Beijing, China", 
          "id": "http://www.grid.ac/institutes/grid.452694.8", 
          "name": [
            "Department of Urology Peking University Shougang Hospital, Wujieping Urology Medical Center, 100144, Beijing, China"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Jin", 
        "givenName": "Lianchao", 
        "id": "sg:person.0721622340.77", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0721622340.77"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Urology Peking University Shougang Hospital, Wujieping Urology Medical Center, 100144, Beijing, China", 
          "id": "http://www.grid.ac/institutes/grid.452694.8", 
          "name": [
            "Department of Urology Peking University Shougang Hospital, Wujieping Urology Medical Center, 100144, Beijing, China"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Zhang", 
        "givenName": "Xianghua", 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1038/gt.2011.136", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1046415671", 
          "https://doi.org/10.1038/gt.2011.136"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1186/1477-7819-10-3", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1046281828", 
          "https://doi.org/10.1186/1477-7819-10-3"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s10330-011-0864-x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1029186694", 
          "https://doi.org/10.1007/s10330-011-0864-x"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/gt.2011.51", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1053425809", 
          "https://doi.org/10.1038/gt.2011.51"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/cgt.2011.35", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1037413233", 
          "https://doi.org/10.1038/cgt.2011.35"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2013-11", 
    "datePublishedReg": "2013-11-01", 
    "description": "The absence of effective therapies for castration-resistant prostate cancer (CRPC) establishes the need to develop novel therapeutic modality, such as targeted gene therapy, which is ideal for the treatment of CRPC. But its application has been limited due to lack of favorable gene vector and the reduction of \u201cbystander effect\u201d. Consequently, scientists all over the world focus their main experimental research on the following four aspects: targeted gene, vector, transfer means and comprehensive therapy. In this paper, we reviewed the latest advances of experimental research on targeted gene therapy for prostate cancer.", 
    "genre": "article", 
    "id": "sg:pub.10.1007/s10330-013-1241-8", 
    "inLanguage": "en", 
    "isAccessibleForFree": false, 
    "isPartOf": [
      {
        "id": "sg:journal.1032171", 
        "issn": [
          "2095-9621", 
          "1613-9089"
        ], 
        "name": "The Chinese-German Journal of Clinical Oncology", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "11", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "12"
      }
    ], 
    "keywords": [
      "castration-resistant prostate cancer", 
      "prostate cancer", 
      "treatment of CRPC", 
      "targeted gene therapy", 
      "gene therapy", 
      "novel therapeutic modalities", 
      "comprehensive therapy", 
      "effective therapy", 
      "therapeutic modalities", 
      "therapy", 
      "cancer", 
      "bystander effect", 
      "latest advances", 
      "modalities", 
      "treatment", 
      "advances", 
      "absence", 
      "genes", 
      "lack", 
      "reduction", 
      "effect", 
      "gene vectors", 
      "need", 
      "research", 
      "experimental research", 
      "aspects", 
      "vector", 
      "means", 
      "world", 
      "applications", 
      "scientists", 
      "paper", 
      "transfer means", 
      "favorable gene vector", 
      "main experimental research"
    ], 
    "name": "The latest advances of experimental research on targeted gene therapy for prostate cancer", 
    "pagination": "546-550", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1052773128"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/s10330-013-1241-8"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/s10330-013-1241-8", 
      "https://app.dimensions.ai/details/publication/pub.1052773128"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2022-01-01T18:30", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20220101/entities/gbq_results/article/article_604.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1007/s10330-013-1241-8"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s10330-013-1241-8'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s10330-013-1241-8'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s10330-013-1241-8'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s10330-013-1241-8'


 

This table displays all metadata directly associated to this object as RDF triples.

133 TRIPLES      22 PREDICATES      68 URIs      53 LITERALS      6 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/s10330-013-1241-8 schema:about anzsrc-for:10
2 anzsrc-for:1004
3 anzsrc-for:11
4 anzsrc-for:1112
5 schema:author Nad849f65afca4a94a65aba75b469d160
6 schema:citation sg:pub.10.1007/s10330-011-0864-x
7 sg:pub.10.1038/cgt.2011.35
8 sg:pub.10.1038/gt.2011.136
9 sg:pub.10.1038/gt.2011.51
10 sg:pub.10.1186/1477-7819-10-3
11 schema:datePublished 2013-11
12 schema:datePublishedReg 2013-11-01
13 schema:description The absence of effective therapies for castration-resistant prostate cancer (CRPC) establishes the need to develop novel therapeutic modality, such as targeted gene therapy, which is ideal for the treatment of CRPC. But its application has been limited due to lack of favorable gene vector and the reduction of “bystander effect”. Consequently, scientists all over the world focus their main experimental research on the following four aspects: targeted gene, vector, transfer means and comprehensive therapy. In this paper, we reviewed the latest advances of experimental research on targeted gene therapy for prostate cancer.
14 schema:genre article
15 schema:inLanguage en
16 schema:isAccessibleForFree false
17 schema:isPartOf N848c6aacbf40498fbd6768b53168fd39
18 Nf65e2f6fcdc94b26a74080af219a904b
19 sg:journal.1032171
20 schema:keywords absence
21 advances
22 applications
23 aspects
24 bystander effect
25 cancer
26 castration-resistant prostate cancer
27 comprehensive therapy
28 effect
29 effective therapy
30 experimental research
31 favorable gene vector
32 gene therapy
33 gene vectors
34 genes
35 lack
36 latest advances
37 main experimental research
38 means
39 modalities
40 need
41 novel therapeutic modalities
42 paper
43 prostate cancer
44 reduction
45 research
46 scientists
47 targeted gene therapy
48 therapeutic modalities
49 therapy
50 transfer means
51 treatment
52 treatment of CRPC
53 vector
54 world
55 schema:name The latest advances of experimental research on targeted gene therapy for prostate cancer
56 schema:pagination 546-550
57 schema:productId N6691665a7cdf49dab6ed08c774ed5859
58 Ncf7cf3780fc041028c0a642ae4432031
59 schema:sameAs https://app.dimensions.ai/details/publication/pub.1052773128
60 https://doi.org/10.1007/s10330-013-1241-8
61 schema:sdDatePublished 2022-01-01T18:30
62 schema:sdLicense https://scigraph.springernature.com/explorer/license/
63 schema:sdPublisher N734eef79514e4cbe95169b03b6d3bb0a
64 schema:url https://doi.org/10.1007/s10330-013-1241-8
65 sgo:license sg:explorer/license/
66 sgo:sdDataset articles
67 rdf:type schema:ScholarlyArticle
68 N1da80f2c8dee4354b3860eed64e1ef6c schema:affiliation grid-institutes:grid.452694.8
69 schema:familyName Zhang
70 schema:givenName Xianghua
71 rdf:type schema:Person
72 N275d1e7430d54c29aee17944e4056c5b rdf:first sg:person.0721622340.77
73 rdf:rest Nb922fbc656204626a0246dcac7c40d7c
74 N62162896eec6488193d55e7bf377cf9c schema:affiliation grid-institutes:grid.452694.8
75 schema:familyName Pan
76 schema:givenName Dongliang
77 rdf:type schema:Person
78 N6691665a7cdf49dab6ed08c774ed5859 schema:name doi
79 schema:value 10.1007/s10330-013-1241-8
80 rdf:type schema:PropertyValue
81 N734eef79514e4cbe95169b03b6d3bb0a schema:name Springer Nature - SN SciGraph project
82 rdf:type schema:Organization
83 N848c6aacbf40498fbd6768b53168fd39 schema:issueNumber 11
84 rdf:type schema:PublicationIssue
85 Nad849f65afca4a94a65aba75b469d160 rdf:first N62162896eec6488193d55e7bf377cf9c
86 rdf:rest N275d1e7430d54c29aee17944e4056c5b
87 Nb922fbc656204626a0246dcac7c40d7c rdf:first N1da80f2c8dee4354b3860eed64e1ef6c
88 rdf:rest rdf:nil
89 Ncf7cf3780fc041028c0a642ae4432031 schema:name dimensions_id
90 schema:value pub.1052773128
91 rdf:type schema:PropertyValue
92 Nf65e2f6fcdc94b26a74080af219a904b schema:volumeNumber 12
93 rdf:type schema:PublicationVolume
94 anzsrc-for:10 schema:inDefinedTermSet anzsrc-for:
95 schema:name Technology
96 rdf:type schema:DefinedTerm
97 anzsrc-for:1004 schema:inDefinedTermSet anzsrc-for:
98 schema:name Medical Biotechnology
99 rdf:type schema:DefinedTerm
100 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
101 schema:name Medical and Health Sciences
102 rdf:type schema:DefinedTerm
103 anzsrc-for:1112 schema:inDefinedTermSet anzsrc-for:
104 schema:name Oncology and Carcinogenesis
105 rdf:type schema:DefinedTerm
106 sg:journal.1032171 schema:issn 1613-9089
107 2095-9621
108 schema:name The Chinese-German Journal of Clinical Oncology
109 schema:publisher Springer Nature
110 rdf:type schema:Periodical
111 sg:person.0721622340.77 schema:affiliation grid-institutes:grid.452694.8
112 schema:familyName Jin
113 schema:givenName Lianchao
114 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0721622340.77
115 rdf:type schema:Person
116 sg:pub.10.1007/s10330-011-0864-x schema:sameAs https://app.dimensions.ai/details/publication/pub.1029186694
117 https://doi.org/10.1007/s10330-011-0864-x
118 rdf:type schema:CreativeWork
119 sg:pub.10.1038/cgt.2011.35 schema:sameAs https://app.dimensions.ai/details/publication/pub.1037413233
120 https://doi.org/10.1038/cgt.2011.35
121 rdf:type schema:CreativeWork
122 sg:pub.10.1038/gt.2011.136 schema:sameAs https://app.dimensions.ai/details/publication/pub.1046415671
123 https://doi.org/10.1038/gt.2011.136
124 rdf:type schema:CreativeWork
125 sg:pub.10.1038/gt.2011.51 schema:sameAs https://app.dimensions.ai/details/publication/pub.1053425809
126 https://doi.org/10.1038/gt.2011.51
127 rdf:type schema:CreativeWork
128 sg:pub.10.1186/1477-7819-10-3 schema:sameAs https://app.dimensions.ai/details/publication/pub.1046281828
129 https://doi.org/10.1186/1477-7819-10-3
130 rdf:type schema:CreativeWork
131 grid-institutes:grid.452694.8 schema:alternateName Department of Urology Peking University Shougang Hospital, Wujieping Urology Medical Center, 100144, Beijing, China
132 schema:name Department of Urology Peking University Shougang Hospital, Wujieping Urology Medical Center, 100144, Beijing, China
133 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...